Table 1 Clinical features, psychological and related-disability outcomes in patients with tension-type headache in the total sample and by symptomatic medication intake (n = 168)
Total sample (n = 168) | Taking medication (n = 136) | No taking medication (n = 32) | |
|---|---|---|---|
Clinical Pain Features | |||
Gender (male/female) n (%) | 45 (27%) / 123 (73%) | 36 (27%) / 100 (73%) | 9 (31%) / 23 (72%) |
FETTH / CTTH n (%)a | 94 (56%) / 74 (44%) | 82 (60%) / 54 (40%) | 12 (38%) / 20 (62%) |
Age (years) | 46 (44, 48) | 45 (42, 48) | 48 (43, 53) |
Headache history (years) | 10.5 (8.9, 12.1) | 10.8 (8.8, 12.8) | 10.2 (7.1, 13.3) |
Headache intensity (0–10) | 6.1 (5.7, 6.5) | 6.0 (5.4, 6.6) | 6.6 (5.8, 7.4) |
Headache frequency (days/month) a | 16.7 (12.5, 20.9) | 16.2 (14.0, 18.4) | 19.3 (17.8, 20.8) |
Headache duration (hours per attack) | 7.3 (6.6, 8.0) | 7.2 (6.4, 8.0) | 7.6 (6.0, 9.2) |
Prophylactic medication n (%) | 40 (25%) | 16 (12%) | 24 (75%) |
Psychological and disability-related outcomes | |||
HADS-D (0–21) a | 8.4 (7.7, 9.1) | 7.5 (6.7, 8.3) | 9.5 (8.0, 11.0) |
HADS-A (0–21) | 10.7 (9.7, 11.7) | 10.7 (9.8, 11.6) | 10.6 (9.0, 12.2) |
HDI-P (0–48) | 23.0 (21.8, 24.2) | 22.5 (20.2, 24.8) | 23.2 (18,6, 27.8) |
HDI-E (0–52) | 19.7 (17.5, 21.9) | 18.0 (15.5, 20.5) | 22.2 (16.5, 27.9) |
STAI-T (0–60) | 23.9 (22.7, 25.1) | 23.8 (22.4, 25.2) | 24.2 (21.3, 27.3) |
STAI-S (0–60) | 21.8 (20.8, 22.8) | 21.6 (20.5, 22.7) | 22.2 (20.3, 24.1) |
PSQI (0–21) | 8.0 (7.2, 8.8.) | 8.2 (7.5, 8.9) | 7.8 (5.8, 9.8) |